News

Discontinuing a recalled drug could cause more immediate harm than staying on the medication. Prinston said the following irbesartan and irbesartan hydrochlorothiazide tablets have been recalled ...
Two types of blood pressure medication made by the company Lupin Pharmaceuticals are being recalled because they may contain high levels of a substance that could cause cancer. The Food and Drug ...
Irbesartan and Hydrochlorothiazide tablet USP, 150mg/12.5mg and 300mg/12.5mg were also packaged in 30- and 90-count bottles and distributed to wholesalers, drug chains, mail-order pharmacies and ...
Lupin Pharmaceuticals is recalling all batches of irbesartan tablets USP 75 mg, 150 mg, and 300 mg and irbesartan and hydrochlorothiazide (HCTZ) tablets USP 150 mg/12.5 mg and 300 mg/12.5 mg ...
Learn the correct pronunciation of the Irbesartan and Hydrochlorothiazide , understand it's uses, recommended dosages, its indications, how to take, when to take, when not to take, side effects ...
All batches of Irbesartan tablets in 75 mg, 150 mg and 300 mg strengths and Irbesartan and Hydrochlorothiazide tablets in 150 mg/12.5 mg and 300 mg/12.5 mg strengths made by Lupin Pharmaceuticals ...
This combination medication contains angiotensin II receptor blocker and diuretic, prescribed for high blood pressure.
Teva announced the launch of Irbesartan and Irbesartan/Hydrochlorothiazide tablets, the generic versions of Bristol-Myers Squibb‘s Avapro and Avalide tablets. Avapro is an angiotensin II ...
Certain Irbesartan tablets and Irbesartan and Hydrochlorothiazide tablets contain more of the impurity N-nitrosoirbesartan (a potential carcinogen) than is safe. Patients are advised to keep ...
Back to Healio Lupin is voluntarily recalling batches of irbesartan and irbesartan/hydrochlorothiazide tablets after an analysis revealed that certain tested active pharmaceutical ingredient ...
Three additional lots of losartan potassium tablets and two additional lots of losartan potassium/hydrochlorothiazide ... losartan and irbesartan that contain trace levels of carcinogens ...